By Professor John Frederick Knight

Book Chapters

KNIGHT JF; FALK MC; NG G; FANNING GC; ARTLETT CM; ROY LP, 1995, 'IgA nephropathy: Immunogenetic studies of Australian patients', in Clarkson AR; Woodroffe AJ (ed.), , KARGER, pp. 18 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995BC71Y00004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

BAUR LA; ALLEN BJ; ALLEN R; COWELL CT; DORNEY SFA; KNIGHT JF; GASKIN KJ, 1993, 'TOTAL-BODY NITROGEN IN IDIOPATHIC SHORT STATURE AND CHRONIC DISEASES OF CHILDHOOD', in Ellis KJ; Eastman JD (ed.), , PLENUM PRESS DIV PLENUM PUBLISHING CORP, pp. 143 - 146, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993BZ43M00032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Knight JF; Harada T; Thomas MA; Frampton G; Savage CO; Chantler C; Williams DG, 1988, 'IgA rheumatoid factor and other autoantibodies in acute Henoch-Schönlein purpura.', in , pp. 117 - 120, http://dx.doi.org/10.1159/000415386

Journal articles

McAlister S; Talbot B; Knight J; Blair S; McGain F; McDonald S; Nelson C; Knight R; Barraclough KA, 2024, 'The Carbon Footprint of Peritoneal Dialysis in Australia', Journal of the American Society of Nephrology, 35, pp. 1095 - 1103, http://dx.doi.org/10.1681/ASN.0000000000000361

Luyckx VA; Alasfar S; Bajpai D; Atwater CE; Knight J; Talbot B; Davies S; Niang A, 2024, 'Providing environmentally sustainable nephrology care: focus in low- and middle-income countries', Kidney International, 105, pp. 259 - 268, http://dx.doi.org/10.1016/j.kint.2023.09.034

TALBOT B; Davies S; Burman J; Ritchie A; Snelling P; Lynch S; Park Y; Jones B; Garvey V; Jaure A; Jardine M; Perkovic V; Gallagher M; Brandwood A; Knight J, 2023, 'WCN23-0574 THE ELLEN MEDICAL DEVICES AFFORDABLE POINT-OF-CARE PERITONEAL DIALYSIS SYSTEM - A PILOT STUDY', Kidney International Reports, 8, pp. S350 - S350, http://dx.doi.org/10.1016/j.ekir.2023.02.786

Talbot B; Farnbach S; Tong A; Chadban S; Sen S; Garvey V; Gallagher M; Knight J, 2022, 'Patient and Clinician Perspectives on the use of Remote Patient Monitoring in Peritoneal Dialysis', Canadian Journal of Kidney Health and Disease, 9, http://dx.doi.org/10.1177/20543581221084499

Pett J; Mohamed F; Knight J; Linhart C; Osborne NJ; Taylor R, 2022, 'Two decades of chronic kidney disease of unknown aetiology (CKDu) research: Existing evidence and persistent gaps from epidemiological studies in Sri Lanka', Nephrology, 27, pp. 238 - 247, http://dx.doi.org/10.1111/nep.13989

John MD O; Arfin S; Paul S; Bassi A; Knight J; Jha V, 2021, 'POS-527 CONTINUUM OF CARE AMONG PARTICIPANTS OF DIALYSIS OUTCOMES REGISTRY IN INDIA DURING THE COVID-19 PANDEMIC LOCKDOWN', Kidney International Reports, 6, pp. S230 - S230, http://dx.doi.org/10.1016/j.ekir.2021.03.555

Zhang H; Rogers K; Sukkar L; Jun M; Kang A; Young T; Campain A; Cass A; Chow CK; Comino E; Foote C; Gallagher M; Knight J; Liu B; Lung T; McNamara M; Peiris D; Pollock C; Sullivan D; Wong G; Zoungas S; Jardine M; Hockham C, 2020, 'Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected data', Journal of Clinical and Translational Endocrinology, 22, pp. 100240, http://dx.doi.org/10.1016/j.jcte.2020.100240

Zhang GY; Hu M; Watson D; Wang YM; Knight JF; Alexander S, 2020, 'Indirectly Activated Treg Allow Dominant Tolerance to Murine Skin-grafts Across an MHC Class I Mismatch After a Single Donor-specific Transfusion', TRANSPLANTATION, 104, pp. 1385 - 1395, http://dx.doi.org/10.1097/TP.0000000000003173

Sukkar L; Kang A; Hockham C; Young T; Jun M; Foote C; Pecoits-Filho R; Neuen B; Rogers K; Pollock C; Cass A; Sullivan D; Wong G; Knight J; Peiris D; Gallagher M; Jardine M, 2020, 'Incidence and associations of chronic kidney disease in community participants with diabetes: A 5-year prospective analysis of the EXTEND45 study', Diabetes Care, 43, pp. 982 - 990, http://dx.doi.org/10.2337/dc19-1803

Foote C; Hockham C; Sukkar L; Campain A; Kang A; Young T; Cass A; Chow CK; Comino E; Gallagher M; Jan S; Knight J; Liu B; McNamara M; Peiris D; Pollock C; Sullivan D; Wong G; Zoungas S; Rogers K; Jun M; Jardine M; Harris M, 2020, 'Examining outcomes in chronic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study', JMIR Research Protocols, 9, pp. e15646, http://dx.doi.org/10.2196/15646

Foote C; Hockham C; Sukkar L; Campain A; Kang A; Young T; Cass A; Chow CK; Comino E; Gallagher M; Jan S; Knight J; Liu B; McNamara M; Peiris D; Pollock C; Sullivan D; Wong G; Zoungas S; Rogers K; Jun M; Jardine M, 2020, 'Examining outcomes in chronic disease in the 45 and up study (the EXTEnD45 study): Protocol for an Australian linked cohort study', JMIR Research Protocols, 9, pp. e15646, http://dx.doi.org/10.2196/15646

TALBOT B; Sood A; Smyth B; Leishman G; Garvey V; Kaur N; Knight J, 2020, 'SAT-273 EARLY DETECTION OF PERITONITIS - A NOVEL APPROACH TO PERITONEAL EFFLUENT TURBIDITY', Kidney International Reports, 5, pp. S116 - S117, http://dx.doi.org/10.1016/j.ekir.2020.02.290

BASSI A; John O; Shah D K; Kolli S; Angell B; Jan S; Joshi R; Kotwal S; Gallagher M; Knight J; Jha V, 2020, 'SAT-299 Change in Health-Related Quality of Life over 18 Months among Individuals on Maintenance Haemodialysis in India', Kidney International Reports, 5, pp. S126 - S126, http://dx.doi.org/10.1016/j.ekir.2020.02.318

Bassi A; John MD O; Joshi R; Kotwal S; Angell B; Jan S; Gallagher M; Knight J; Jha V, 2020, 'SUN-180 SOCIO-DEMOGRAPHIC CHARACTERISTICS AND OUTCOMES AT 18 MONTHS OF A COHORT OF ESKD PATIENTS STARTING HEMODIALYSIS IN INDIA', Kidney International Reports, 5, pp. S273 - S274, http://dx.doi.org/10.1016/j.ekir.2020.02.713

Bassi A; John O; Gallagher M; Kotwal S; Joshi R; Essue B; Jan S; Ramachandran R; Kher V; Knight J; Jha V, 2019, 'Methodological challenges to collecting clinical and economic outcome data: Lessons from the pilot dialysis outcomes India study', Nephrology, 24, pp. 445 - 449, http://dx.doi.org/10.1111/nep.13257

BASSI A; John O; Joshi R; Kotwal S; Shah K; Angell B; Jan S; Gallagher M; Knight J; Jha V, 2019, 'SAT-039 Socio-Demographic Characteristics, Out of Pocket Expenditure, Quality of Life and Six Months Treatment Outcomes of Haemodialysis Patients in India', Kidney International Reports, 4, pp. S20 - S20, http://dx.doi.org/10.1016/j.ekir.2019.05.062

Agar J; Barraclough K; Sypek M; Knight J, 2019, 'SAT-339 Understanding the Environmental Footprints of Nephrology and Dialysis', Kidney International Reports, 4, pp. S150 - S150, http://dx.doi.org/10.1016/j.ekir.2019.05.387

Barraclough K; Knight J; Sypek M; Agar J, 2019, 'SAT-343 PROGRESS TOWARDS ENVIRONMENTALLY SUSTAINABLE RENAL CARE IN AUSTRALIA AND NEW ZEALAND', Kidney International Reports, 4, pp. S152 - S152, http://dx.doi.org/10.1016/j.ekir.2019.05.391

TALBOT B; Franca Gois P; Healy H; Gallagher A; Sen S; Chadban S; Gallagher M; Knight J; Barraclough K, 2019, 'SUN-058 Variations in Environmentally Sustainable Practice within Australian Dialysis Units: Time for a Nationwide Approach?', Kidney International Reports, 4, pp. S178 - S178, http://dx.doi.org/10.1016/j.ekir.2019.05.454

Shaikh M; Woodward M; John O; Bassi A; Jan S; Sahay M; Taduri G; Gallagher M; Knight J; Jha V, 2018, 'Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India', Kidney International, 94, pp. 440 - 445, http://dx.doi.org/10.1016/j.kint.2018.03.028

Essue BM; Jha V; John O; Knight J; Jan S, 2018, 'Universal health coverage and chronic kidney disease in India', Bulletin of the World Health Organization, 96, pp. 442, http://dx.doi.org/10.2471/BLT.18.208207

Smyth B; Knight JF; Herrington WG, 2016, 'The rise and rise of randomized clinical evidence in Sub-Saharan Africa', Clinical Kidney Journal, 9, pp. 814 - 816, http://dx.doi.org/10.1093/ckj/sfw084

Knight J; Perkovic V, 2016, 'The Affordable Dialysis Prize steams ahead', The Lancet, 387, pp. 1040, http://dx.doi.org/10.1016/S0140-6736(16)00657-7

Liyanage T; Ninomiya T; Jha V; Neal B; Patrice HM; Okpechi I; Zhao MH; Lv J; Garg AX; Knight J; Rodgers A; Gallagher M; Kotwal S; Cass A; Perkovic V, 2015, 'Worldwide access to treatment for end-stage kidney disease: A systematic review', The Lancet, 385, pp. 1975 - 1982, http://dx.doi.org/10.1016/S0140-6736(14)61601-9

Jha V; John O; Joshi R; Kotwal S; Essue B; Jan S; Gallagher M; Knight J, 2015, 'Dialysis outcomes in India: A pilot study', Nephrology, 20, pp. 329 - 334, http://dx.doi.org/10.1111/nep.12404

Wong MG; Wanner C; Knight J; Perkovic V, 2015, 'Lowering cholesterol in chronic kidney disease: Is it safe and effective?', European Heart Journal, 36, pp. 2988 - 2995, http://dx.doi.org/10.1093/eurheartj/ehv393

Palmer SC; Ruospo M; Campbell KL; Larsen VG; Saglimbene V; Natale P; Gargano L; Craig JC; Johnson DW; Tonelli M; Knight J; Bednarek-Skublewska A; Celia E; del Castillo D; Dulawa J; Ecder T; Fabricius E; Frazao JM; Gelfman R; Hoischen SH; Schoen S; Stroumza P; Timofte D; Toeroek M; Hegbrant J; Wollheim C; Frantzen L; Strippoli GFM, 2015, 'Nutrition and dietary intake and their association with mortality and hospitalisation in adults with chronic kidney disease treated with haemodialysis: protocol for DIET-HD, a prospective multinational cohort study', BMJ OPEN, 5, http://dx.doi.org/10.1136/bmjopen-2014-006897

Knight J; Wong MG; Perkovic V, 2014, 'Optimal targets for blood pressure control in chronic kidney disease: The debate continues', Current Opinion in Nephrology and Hypertension, 23, pp. 541 - 546, http://dx.doi.org/10.1097/MNH.0000000000000060

Wu H; Wang YM; Wang Y; Hu M; Zhang GY; Knight JF; Harris DCH; Alexander SI, 2007, 'Depletion of γδ T cells exacerbates murine adriamycin nephropathy', Journal of the American Society of Nephrology, 18, pp. 1180 - 1189, http://dx.doi.org/10.1681/ASN.2006060622

Lee A; Cooper MG; Craig JC; Knight JF; Keneally JP, 2007, 'Effects of nonsteroidal anti-inflammatory drugs on postoperative renal function in adults with normal renal function', COCHRANE DATABASE OF SYSTEMATIC REVIEWS, http://dx.doi.org/10.1002/14651858.CD002765.pub3

Vimalachandra D; Hodson EM; Willis NS; Craig JC; Cowell C; Knight JF, 2006, 'Growth hormone for children with chronic kidney disease', COCHRANE DATABASE OF SYSTEMATIC REVIEWS, http://dx.doi.org/10.1002/14651858.CD003264.pub2

Boven K; Stryker S; Knight J; Thomas A; van Regenmortel M; Kemeny DM; Power D; Rossert J; Casadevall NE, 2005, 'The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes', KIDNEY INTERNATIONAL, 67, pp. 2346 - 2353, http://dx.doi.org/10.1111/j.1523-1755.2005.00340.x

Boven K; Knight J; Bader F; Rossert K; Eckardt KU; Casadevall N, 2005, 'Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery', NEPHROLOGY DIALYSIS TRANSPLANTATION, 20, pp. III33 - III40, http://dx.doi.org/10.1093/ndt/gfh1072

Hodson EM; Knight JF; Willis NS; Craig JC, 2005, 'Corticosteroid therapy for nephrotic syndrome in children', COCHRANE DATABASE OF SYSTEMATIC REVIEWS, http://dx.doi.org/10.1002/14651858.CD001533.pub3

Hu M; Zhang GY; Walters G; Sartor M; Watson D; Knight JF; Alexander SI, 2004, 'Matching T-cell receptors identified in renal biopsies and urine at the time of acute rejection in pediatric renal transplant patients', AMERICAN JOURNAL OF TRANSPLANTATION, 4, pp. 1859 - 1868, http://dx.doi.org/10.1111/j.1600-6143.2004.00587.x

Wu H; Knight JF; Alexander SI, 2004, 'Regulatory gamma delta T cells in Heymann nephritis express an invariant Vγ6/Vδ1 with a canonical CDR3 sequence', European Journal of Immunology, 34, pp. 2322 - 2330, http://dx.doi.org/10.1002/eji.200324780

Walters G; Habib AM; Reynolds J; Wu HL; Knight JF; Pusey CD, 2004, 'Glomerular T cells are of restricted clonality and express multiple CDR3 motifs across different V beta T-cell receptor families in experimental autoimmune glomerulonephritis', NEPHRON EXPERIMENTAL NEPHROLOGY, 98, pp. E71 - E81, http://dx.doi.org/10.1159/000080682

Cumming RG; Mitchell P; Craig JC; Knight JF, 2004, 'Renal impairment and anaemia in a population-based study of older people', INTERNAL MEDICINE JOURNAL, 34, pp. 20 - 23, http://dx.doi.org/10.1111/j.1444-0903.2004.00472.x

Lee A; Cooper MC; Craig JC; Knight JF; Keneally JP, 2004, 'Effects of nonsteroidal anti-inflammatory drugs on postoperative renal function in adults with normal renal function.', Cochrane Database Syst Rev, pp. CD002765, http://dx.doi.org/10.1002/14651858.CD002765.pub2

Wu HL; Walters G; Knight JF; Alexander SI, 2003, 'DNA vaccination against specific pathogenic TCRs reduces proteinuria in active Heymann nephritis by inducing specific autoantibodies', JOURNAL OF IMMUNOLOGY, 171, pp. 4824 - 4829, http://dx.doi.org/10.4049/jimmunol.171.9.4824

Sureshkumar P; Bower W; Craig JC; Knight JF, 2003, 'Treatment of daytime urinary incontinence in children: A systematic review of randomized controlled trials', JOURNAL OF UROLOGY, 170, pp. 196 - 200, http://dx.doi.org/10.1097/01.ju.0000072341.34333.43

Hodson EM; Knight JF; Willis NS; Craig JC, 2003, 'Corticosteroid therapy for nephrotic syndrome in children.', Cochrane Database Syst Rev, pp. CD001533, http://dx.doi.org/10.1002/14651858.CD001533

Buck KS; Foster EM; Watson D; Barratt J; Pawluczyk IZA; Knight JF; Feehally J; Allen AC, 2002, 'Expression of T cell receptor variable region families by bone marrow gamma delta T cells in patients with IgA nephropathy', CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 127, pp. 527 - 532, http://dx.doi.org/10.1111/j.1365-2249.2002.01784.x

Walters G; Wu H; Knight JF, 2001, 'Glomerular T cells in heymann nephritis', CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 126, pp. 319 - 325, http://dx.doi.org/10.1046/j.1365-2249.2001.01505.x

Vimalachandra D; Craig JC; Cowell CT; Knight JF, 2001, 'Growth hormone treatment in children with chronic renal failure: A meta-analysis of randomized controlled trials', JOURNAL OF PEDIATRICS, 139, pp. 560 - 567, http://dx.doi.org/10.1067/mpd.2001.117582

Ando T; Wu HL; Watson D; Hirano T; Hirakata H; Fujishima M; Knight JF, 2001, 'Infiltration of canonical V gamma 4/V delta 1 gamma delta T cells in an adriamycin-induced progressive renal failure model', JOURNAL OF IMMUNOLOGY, 167, pp. 3740 - 3745, http://dx.doi.org/10.4049/jimmunol.167.7.3740

Wu HL; Clarkson AR; Knight JF, 2001, 'Restricted gamma delta T-cell receptor repertoire in IgA nephropathy renal biopsies', KIDNEY INTERNATIONAL, 60, pp. 1324 - 1331, http://dx.doi.org/10.1046/j.1523-1755.2001.00937.x

Back to profile page